33895780|t|The olfactory route is a potential way for SARS-CoV-2 to invade the central nervous system of rhesus monkeys.
33895780|a|Neurological manifestations are frequently reported in the COVID-19 patients. Neuromechanism of SARS-CoV-2 remains to be elucidated. In this study, we explored the mechanisms of SARS-CoV-2 neurotropism via our established non-human primate model of COVID-19. In rhesus monkey, SARS-CoV-2 invades the CNS primarily via the olfactory bulb. Thereafter, viruses rapidly spread to functional areas of the central nervous system, such as hippocampus, thalamus, and medulla oblongata. The infection of SARS-CoV-2 induces the inflammation possibly by targeting neurons, microglia, and astrocytes in the CNS. Consistently, SARS-CoV-2 infects neuro-derived SK-N-SH, glial-derived U251, and brain microvascular endothelial cells in vitro. To our knowledge, this is the first experimental evidence of SARS-CoV-2 neuroinvasion in the NHP model, which provides important insights into the CNS-related pathogenesis of SARS-CoV-2.
33895780	43	53	SARS-CoV-2	Species	2697049
33895780	94	108	rhesus monkeys	Species	9544
33895780	169	177	COVID-19	Disease	MESH:D000086382
33895780	178	186	patients	Species	9606
33895780	206	216	SARS-CoV-2	Species	2697049
33895780	288	298	SARS-CoV-2	Species	2697049
33895780	336	341	human	Species	9606
33895780	359	367	COVID-19	Disease	MESH:D000086382
33895780	372	385	rhesus monkey	Species	9544
33895780	387	397	SARS-CoV-2	Species	2697049
33895780	592	601	infection	Disease	MESH:D007239
33895780	605	615	SARS-CoV-2	Species	2697049
33895780	628	640	inflammation	Disease	MESH:D007249
33895780	724	734	SARS-CoV-2	Species	2697049
33895780	757	764	SK-N-SH	CellLine	CVCL:0531
33895780	780	784	U251	CellLine	CVCL:0021
33895780	899	909	SARS-CoV-2	Species	2697049
33895780	1013	1023	SARS-CoV-2	Species	2697049

